Kok, N. Et Al. 2025. CD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells. iScience , vol.28, no.6 .

Kok, N., Ozkazanc, D., van Vliet, A. A., Steenmans, D., Singh, S. P., SÜTLÜ, T., ... Georgoudaki, A.(2025). CD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells. iScience , vol.28, no.6.

Kok, Nina Et Al. "CD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells," iScience , vol.28, no.6, 2025

Kok, Nina Et Al. "CD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells." iScience , vol.28, no.6, 2025

Kok, N. Et Al. (2025) . "CD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells." iScience , vol.28, no.6.

@article{article, author={Nina Kok Et Al. }, title={CD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells}, journal={iScience}, year=2025}